University of Maryland School of Medicine: Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent Malaria
January 27, 2023
January 27, 2023
BALTIMORE, Maryland, Jan. 27 (TNSjou) -- The University of Maryland School of Medicine issued the following news:
* * *
University of Maryland School of Medicine Researchers Found CIS43LS to be Safe, Well Tolerated in Human Challenge Trial
* * *
A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, . . .
* * *
University of Maryland School of Medicine Researchers Found CIS43LS to be Safe, Well Tolerated in Human Challenge Trial
* * *
A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, . . .